In a prediction model for adverse outcomes in hospitalized patients with DM2 developed by Nirantharakumar et al., decreased albumin levels (albumin 25–34 g/L, OR = 1.74, albumin < 25 g/L OR = 2.64, p < 0.001) and reduced eGFR (eGFR < 30 mL/min/1.73 m2, OR = 1.31, p < 0.001) were associated with extended LOS and mortality, supporting our current findings (albumin OR = 0.936, eGFR OR = 0.994, p < 0.001) [34]. Here, ALB is linked to myotonic dystrophy type 2.